Maple Securities USA’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-37,104
Closed -$3.46M 20
2015
Q3
$3.46M Buy
37,104
+17
+0% +$1.65K 0.44% 13
2015
Q2
$3.61M Sell
37,087
-59,626
-62% -$5.97M 0.34% 23
2015
Q1
$9.73M Buy
96,713
+8,705
+10% +$885K 0.82% 14
2014
Q4
$9.2M Buy
88,008
+86,019
+4,325% +$9.06M 0.73% 17
2014
Q3
$212K Sell
1,989
-179,962
-99% -$18.7M 0.02% 214
2014
Q2
$19M Buy
181,951
+162,992
+860% +$16.5M 2.1% 4
2014
Q1
$1.86M Sell
18,959
-17,132
-47% -$1.59M 0.16% 29
2013
Q4
$3.31M Sell
36,091
-146,268
-80% -$13.5M 0.24% 31
2013
Q3
$15.8M Buy
182,359
+65,007
+55% +$5.83M 1.26% 13
2013
Q2
$10.1M Buy
+117,352
New +$9.96M 0.92% 12

Other funds holding JNJ

Maple Securities USA's JNJ Position: Q4 2015 in Review

Maple Securities USA sold out of Johnson & Johnson (JNJ) in Q4 2015, closing a stake of 37,104 shares — an estimated $3.46M sold.

Maple Securities USA first reported a position in JNJ in Q2 2013 and held it in 10 quarters. The position peaked at $19M in Q2 2014. 2,192 funds tracked by Wall St. Rank hold JNJ as of Q4 2015.

  • Maple Securities USA reported no remaining Johnson & Johnson position as of Q4 2015 after selling out during the quarter.
  • Maple Securities USA sold 37,104 Johnson & Johnson shares in Q4 2015, an estimated $3.46M.
  • Maple Securities USA first reported a position in Johnson & Johnson in Q2 2013 and held it in 10 quarters.
  • Maple Securities USA's Johnson & Johnson position peaked at $19M in Q2 2014.
  • 2,192 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2015.

Based on Maple Securities USA's 13F filing for Q4 2015, filed 15 Jan 2016.